Lilly's Experimental Drug Tops Ozempic for Weight Loss in Trial
Fact checked by NewsPlainVerified by NewsPlain: confirmed by at least two named sources
Brief
People with Type 2 diabetes who took Eli Lilly's experimental drug retatrutide lost about twice as much weight as those on Ozempic, Lilly said…
Keep reading with NewsPlain Premium
Get the full brief, the full story, what's confirmed, what's still unclear, why it matters, and every source.
2 sources behind this story.